The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Diabetes is a major cause of visual impairment among working-age adults in the United States. The proliferative form of diabetic retinopathy is associated with severe vision loss (acuity <5/200). The standard treatment in proliferative diabetic retinopathy (PDR) is panretinal photocoagulation (PR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs in Context Jg. 7; S. 212532 - 10
Hauptverfasser:	Zhao, Yue, Singh, Rishi P
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England BioExcel Publishing Ltd 13.08.2018
Schlagworte:	aflibercept angiogenesis inhibitors antibodies bevacizumab diabetic retinopathy humanized antibodies intravitreal injection monoclonal ranibizumab Review vascular endothelial growth factor A aflibercept bevacizumab antibodies monoclonal intravitreal injection angiogenesis inhibitors diabetic retinopathy vascular endothelial growth factor A humanized antibodies ranibizumab
ISSN:	1745-1981, 1740-4398, 1740-4398
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!